Storia in 3 fonti

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S.

The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.

Raccontata da

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

cnbc.comStai leggendo7 mesi fa

The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.

First and only GLP-1 pill on the market costs significantly less than injectable versions